Unprecedented Four-Week Run in Fed Cattle Prices Linked to Solid Export Demand, Strong Markets

 

According to Jim Robb, executive director of the Livestock Marketing Information Center, the four-week run-up in slaughter cattle markets and higher wholesale boxed beef trade has been unprecedented. He told Radio Oklahoma Ag Network Farm Director Ron Hays it is because certain factors in the marketplace have converged into the perfect storm, so to speak, that has spurred the dramatic leap in prices. He says in particular, strength in the export market has had a lot to do with it.

 

“This has been the best March that we’ve had since 2011 in terms of US beef export tonnage,” he said, noting that USDA has reported a 25 percent increase. “That export market is clearly part of the reason that packers have had to chase cattle supplies.”

 

And it’s not because of winter weather that producers have seen lower carcass weights being pushed through either. In reality, it has been the because of the aggressive marketing that has been done since last fall.

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.